EchoDolphin Showcases at HUAWEI CONNECT 2026 | Powered by Ascend AI, Making Endoscopic Diagnosis and Treatment “Traceable”

Oct 8, 2026


[Shanghai, China, September 17, 2026] HUAWEI CONNECT 2026 opened in Shanghai. As an important partner of Huawei in the field of medical intelligence, Daichuan Medical was invited to participate in the exhibition and jointly launched “EchoDolphin,” a single-use digestive endoscopy AI diagnosis and treatment platform based on Ascend computing power. Cao Ge, General Manager of Daichuan Medical, and Fan Jie, President of Huawei Pharma Corps, jointly took the stage to complete the launch ceremony, opening a new era of intelligent diagnosis and treatment powered by “device + AI + data.”
 
 
From “Single Examination” to “Continuous Health Management”
Since its debut at last year’s Shenzhen Medical Device Supply Chain Ecosystem Expo, Daichuan EndoFresh® single-use endoscopes have entered more than 10,000 clinical application scenarios, covering emergency care, ICUs, and routine diagnosis and treatment. For many people, undergoing a gastroscopy or colonoscopy used to be like taking a “one-time photo”: once the report was issued, the examination was over; when switching to another device, the data became “disconnected,” and follow-up examinations relied largely on experience.
 
 
Now, we have created an integrated “device + AI + data” single-use endoscopy solution. Powered by the Huawei Ascend Atlas 310P computing card and an edge-side AI BOX accelerated by CANN, the platform connects the full diagnosis and treatment loop of “examination → analysis → follow-up → reassessment,” transforming artificial intelligence technology into real clinical application:
 
For Patients | More Accurate Visualization, More Reassuring Follow-Up
With real-time AI lesion recognition and blind-spot quality control, the platform achieves over 90% accuracy in identifying early cancers and polyps. It supports precise comparison of imaging data across multiple examinations, making lesion evolution clearly visible, such as ulcers and mucosal changes, and helping build a personalized long-term “gastrointestinal health record.”
 
For Doctors | Real-Time Assistance, Evidence-Based Decisions
Real-time AI-assisted diagnosis helps reduce missed diagnoses and alleviate physician fatigue during procedures. Cross-period disease progression data can be retrieved with one click, providing objective and quantitative clinical evidence for follow-up and treatment planning.
 
For Hospitals | Rapid Deployment, Intelligent Upgrade
The combination of an integrated host system and a compact, portable AI BOX supports “plug-and-play” use and can be quickly connected to clinical workflows, helping hospitals build intelligent departments at lower cost and higher efficiency.
 
 
Global Attention and Renewed Recognition of Ecosystem Value
 
At the exhibition, the platform attracted many domestic and international customers and industry experts, including visitors from Southeast Asia, for in-depth exchanges. Discussions focused on its application value in infection control safety, portable deployment, continuous data management, and research empowerment. As the world’s first single-use digestive endoscopy brand to obtain NMPA, MDR, FDA, and PMDA registrations, EndoFresh® is leveraging the systematic ecosystem advantages of “Huawei + EchoDolphin” to accelerate the accessibility and implementation of AI endoscopy worldwide.



 
Healthcare Without Boundaries, Intelligence Taking Root, Making Every Examination Remembered
 
Looking ahead, we will continue to deepen our strategic ecosystem cooperation with Huawei. Relying on Ascend AI chips, we will continuously iterate and upgrade the overall solution for single-use digestive endoscopy across different scenarios. By leveraging the systematic ecosystem advantages of “Huawei + EchoDolphin,” we will continue to unlock the innovative potential of intelligent healthcare and inject new momentum into early gastrointestinal screening, precise and continuous diagnosis and treatment, and clinical research.